RxDoctor Payments Data

Syuzanna Markosyan

Family · Sunland, CANPI 1245075126

Payments from drug & device makers

$545in general payments, 2019–2025

Across 21 payments — averaging $25.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$146
  • Ipsen Biopharmaceuticals, Inc$124
  • Iovance Biotherapeutics, Inc.$33
  • Pharmaessentia USA Corporation$33
  • Merck$29
  • Lilly USA, LLC$27
  • plus $153 from 7 others

What the payments were for

  • Food & beverage$34764%
  • Education$19836%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$545 in reported general payments places this provider in the 60th percentile of 10,634 family providers in California.

See all family providers in California

Medicare billing

Part B allowed, 2024
$354,783
Medicare patients
457
Services billed
31,445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Sunland

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →